Brief: Haemonetics reports Q1 2023 results
10/08/2022 11:12
Aug 10 (Reuters) - Haemonetics Corp HAE.N :
* QTRLY EARNINGS PER SHARE $0.38
* QTRLY ADJUSTED EARNINGS PER SHARE $0.58
* QTRLY REVENUE $261.5 MILLION, UP 14.4%
* SAYS UPDATES FISCAL 2023 GAAP TOTAL REVENUE GROWTH
GUIDANCE TO
8% – 11% FROM 5% – 9%
* Q1 EARNINGS PER SHARE VIEW $0.51, REVENUE VIEW $249.0
MILLION --
REFINITIV IBES DATA
* FY2023 REVENUE VIEW $1.06 BILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nPnb8MVlCa
Further company coverage: HAE.N
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices